TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8859726

Group type: EXPERIMENTAL
Intervention: recombinant interleukin‐2 (rIL‐2) at doses of 3.0, 12.0, and 48.0 x 10(6) IU/m(2) i.v. three times weekly (TIW) and recombinant human IL‐4 (rHuIL‐4) at doses of 40, 120, and 400 mu g/m(2) s.c. TIW
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: recombinant interleukin‐2 (rIL‐2)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: recombinant interleukin‐2 (rIL‐2) and recombinant human IL‐4 (rHuIL‐4)
Number of subjects: 39
Study: 1517910

Group type: EXPERIMENTAL
Intervention: Cow milk-specific antibody responses
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Monitoring casein-specific and beta-lactoglobulin-specific IgE concentrations and IgE/IgG ratios
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IgE-specific antibody concentrations and IgE/IgG-specific ratios for both milk proteins
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IgG1- and IgG4-specific antibody to casein
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IgE/IgG1 and IgE/IgG4 ratios for both casein and beta-lactoglobulin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IgG-specific concentrations
Number of subjects: 29
Study: 6610435

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 90
Study: 30605922

Group type: EXPERIMENTAL
Intervention: HIIT group (n=28)
Number of subjects: 82
Study: 29020023

Group type: EXPERIMENTAL
Intervention: Multimodal anti‐HE intervention (lactulose + branched‐chain amino acids + rifaximin)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Triple placebos
Number of subjects: 44
Study: 26606714

Group type: EXPERIMENTAL
Intervention: Judgment-of-learning (JOL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Re-study
Number of subjects: 0
Study: 25091576

Group type: EXPERIMENTAL
Intervention: T allele (TC + TT genotypes)
Number of subjects: 1075

Group type: COMPARATOR
Intervention: CC genotype
Number of subjects: 1075
Study: 21864417

Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil (1 g/d)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: EPA-rich fish oil (1 g/d)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 19386127

Group type: EXPERIMENTAL
Intervention: Celliant socks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control socks
Number of subjects: 55
Study: 17445520

Group type: EXPERIMENTAL
Intervention: 480 mg caffeine
Number of subjects: 109

Group type: COMPARATOR
Intervention: Caffeine-free (placebo) solution
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Caffeine challenge test
Number of subjects: 109
Study: 16209965

Group type: EXPERIMENTAL
Intervention: Nicorandil (20 mg twice daily)
Number of subjects: 5126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5126

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 5126
Study: 10630938

Group type: EXPERIMENTAL
Intervention: Rigid fixation
Number of subjects: 127

Group type: COMPARATOR
Intervention: Wire fixation
Number of subjects: 127
Study: 8936618

Group type: EXPERIMENTAL
Intervention: Gargling with a remote foot pedal-operated gargling apparatus 3 times during daily work over a 3-month period
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-intervention group (control)
Number of subjects: 0
Study: 1409873

Group type: EXPERIMENTAL
Intervention: Abdominal weights (AbWts)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inspiratory resistive muscle training (IMT)
Number of subjects: 11
Study: 3909167

Group type: EXPERIMENTAL
Intervention: Peri-operative infection prophylaxis by the 'one-shot' method
Number of subjects: 60

Group type: COMPARATOR
Intervention: Peri-operative infection prophylaxis for 48-hour duration
Number of subjects: 60
Study: 30031679

Group type: EXPERIMENTAL
Intervention: GDM patients
Number of subjects: 102

Group type: COMPARATOR
Intervention: non-GDM patients
Number of subjects: 102
Study: 29671381

Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 180

Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 180
Study: 26873871

Group type: EXPERIMENTAL
Intervention: Combined therapy of Exenatide and Metformin (5 μg Exenatide + 0.5 g MET twice daily for 4 weeks, then 10 μg Exenatide + 0.5 g MET twice daily for 24 weeks)
Number of subjects: 105
Study: 23502990

Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 574

Group type: COMPARATOR
Intervention: Control
Number of subjects: 574
Study: 20508383

Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose (FPG) value of 95-99 mg/dL
Number of subjects: 2207

Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose (FPG) value of 100-104 mg/dL
Number of subjects: 2207

Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose (FPG) value of 105-109 mg/dL
Number of subjects: 2207

Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose (FPG) value of 110-114 mg/dL
Number of subjects: 2207

Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose (FPG) value of 115-119 mg/dL
Number of subjects: 2207

Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose (FPG) value of 120-125 mg/dL
Number of subjects: 2207

Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose (FPG) value of 102 mg/dL
Number of subjects: 2207

Group type: EXPERIMENTAL
Intervention: Hemoglobin A(1c) level > or = 6.1%
Number of subjects: 2207
Study: 18353592

Group type: EXPERIMENTAL
Intervention: 4-hydroxy-anethole trithione (ATX) tablets produced by different companies
Number of subjects: 20

Group type: COMPARATOR
Intervention: ATX tablets
Number of subjects: 20
Study: 17117566

Group type: EXPERIMENTAL
Intervention: Acupuncture plus western medicine (treatment group)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Simple western medicine (control group)
Number of subjects: 26
Study: 12842239

Group type: EXPERIMENTAL
Intervention: Cilostazol treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aspirin treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: No antiplatelet agent treatment
Number of subjects: 30
Study: 10923774

Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ondansetron 24 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 120
Study: 8831519

Group type: EXPERIMENTAL
Intervention: Single staple technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Double staple technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinically detected dehiscence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiologically detected dehiscence
Number of subjects: 0
Study: 1335199

Group type: EXPERIMENTAL
Intervention: Resorbable interrupted sutures (Dexon 6x0)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Adhesive plasters (Leukostrip)
Number of subjects: 100
Study: 4032389

Group type: EXPERIMENTAL
Intervention: Lavage with 800 ml of saline plus 2 gm of cefamandole nafate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lavage with 800 ml of saline alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: No lavage
Number of subjects: 0
Study: 31238975

Group type: EXPERIMENTAL
Intervention: gemcitabine plus cisplatin and chemoradiotherapy
Number of subjects: 480

Group type: COMPARATOR
Intervention: chemoradiotherapy alone
Number of subjects: 480
Study: 29977280

Group type: EXPERIMENTAL
Intervention: Action Observation Training (AOT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (landscape-videos observation)
Number of subjects: 64
Study: 27787363

Group type: EXPERIMENTAL
Intervention: Alfentanil 5 μg/kg immediately before propofol administration
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Alfentanil 2.5 μg/kg immediately before propofol administration
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Alfentanil 5 μg/kg 2 minutes before propofol administration
Number of subjects: 173

Group type: COMPARATOR
Intervention: Propofol administration alone (control group 5)
Number of subjects: 173
Study: 24867835

Group type: EXPERIMENTAL
Intervention: Botox treatment
Number of subjects: 688

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 688
Study: 22677437

Group type: EXPERIMENTAL
Intervention: Online group course (Grip op Je Dip / Master Your Mood)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Wait-listed control group
Number of subjects: 244
Study: 20187097

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Predictive model based on multiple linear regressions
Number of subjects: 540
Study: 18599126

Group type: EXPERIMENTAL
Intervention: Client version of the Illness Management and Recovery (IMR) scale
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Clinician version of the Illness Management and Recovery (IMR) scale
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Client responses to the client IMR scale
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Clinician responses to the clinician IMR scale
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Coping efficacy and social support measures (reported by clients)
Number of subjects: 210
Study: 19637997

Group type: EXPERIMENTAL
Intervention: Nanocrystalline hydroxyapatite (NHA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Natural bone mineral in combination with a collagen membrane (NBM+CM)
Number of subjects: 20
Study: 15167475

Group type: EXPERIMENTAL
Intervention: Schilder's warm vertical condensation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Schilder's technique modified by using an electric heater
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Schilder's technique modified by compaction of the apical tract at body temperature
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Modified vertical compaction with apical back‐filling
Number of subjects: 4
Study: 11318057

Group type: EXPERIMENTAL
Intervention: Random practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blocked practice
Number of subjects: 0
Study: 9159678

Group type: EXPERIMENTAL
Intervention: 3.0 mm temporal clear corneal incision
Number of subjects: 80

Group type: COMPARATOR
Intervention: 3.0 mm superior scleral tunnel incision
Number of subjects: 80
Study: 8253560

Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam or clindamycin
Number of subjects: 43
Study: 3521842

Group type: EXPERIMENTAL
Intervention: Intraperitoneal (IP) 5-Fluorouracil (5-FU) chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) 5-Fluorouracil (5-FU) chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pelvic radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5-FU) chemotherapy (both IP and IV)
Number of subjects: 0
Study: 11762429

Group type: EXPERIMENTAL
Intervention: Stimulus control/sleep restriction
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cognitive restructuring
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Relaxation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sleep hygiene
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Imagery training
Number of subjects: 90
Study: 30934886

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30399108

Group type: EXPERIMENTAL
Intervention: Obese women (BMI ≥30)
Number of subjects: 948

Group type: EXPERIMENTAL
Intervention: Overweight women (BMI 25.0-29.9)
Number of subjects: 948

Group type: COMPARATOR
Intervention: Normal-weight women (BMI 18.5-24.9)
Number of subjects: 948

Group type: EXPERIMENTAL
Intervention: Adequate gestational weight gain
Number of subjects: 948

Group type: EXPERIMENTAL
Intervention: Inadequate gestational weight gain
Number of subjects: 948

Group type: EXPERIMENTAL
Intervention: Excessive gestational weight gain
Number of subjects: 948
Study: 27526497

Group type: EXPERIMENTAL
Intervention: Areas designated as nonattainment for PM10
Number of subjects: 4000000

Group type: EXPERIMENTAL
Intervention: Presence of SO2 scrubber on coal-fired power plants
Number of subjects: 4000000
Study: 24571754

Group type: EXPERIMENTAL
Intervention: EV71 vaccine
Number of subjects: 10007

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10007
Study: 22240036

Group type: EXPERIMENTAL
Intervention: Fibromyalgia patients
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Fibromyalgia patients with BDI score≥17
Number of subjects: 126

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 126
Study: 20233669

Group type: EXPERIMENTAL
Intervention: ReNu MultiPlus Multipurpose Solution with PureVision silicon hydrogel contact lens
Number of subjects: 25
Study: 18519845

Group type: EXPERIMENTAL
Intervention: Lisinopril (angiotensin-converting enzyme blocker)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Atenolol (beta-blocker)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Both medications (Lisinopril and Atenolol)
Number of subjects: 28
Study: 15811868

Group type: EXPERIMENTAL
Intervention: PTCA (balloon angioplasty)
Number of subjects: 2082

Group type: EXPERIMENTAL
Intervention: Primary stenting
Number of subjects: 2082

Group type: EXPERIMENTAL
Intervention: Stenting + abciximab
Number of subjects: 2082
Study: 12499819

Group type: EXPERIMENTAL
Intervention: Concurrent chemo‐radiation therapy (external beam radiotherapy 4,500 cGy over 5 weeks and intrahepatic arterial 5‐FU infusion 500 mg on days 1-5 and 30-35)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intrahepatic arterial cisplatin infusion (80 mg/m(2))
Number of subjects: 54
Study: 10417455

Group type: EXPERIMENTAL
Intervention: 25G Whitacre spinal needle
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 25G Quincke spinal needle
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Paraesthesia occurrence
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Number of needle passes
Number of subjects: 130

Group type: COMPARATOR
Intervention: Antiplatelet drug therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Spinal needle type
Number of subjects: 130
Study: 7739736

Group type: EXPERIMENTAL
Intervention: Hib vaccine (administered at 3, 4, 5, and 11 months)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (children born from April 1, 1991 to April 1, 1993 who were not vaccinated)
Number of subjects: 21
Study: 1971472

Group type: EXPERIMENTAL
Intervention: Medetomidine (50 micrograms)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 10
Study: 6996929

Group type: EXPERIMENTAL
Intervention: 3 g magnesium dithiosalicylate daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3 g aspirin daily
Number of subjects: 40
Study: 31409302

Group type: EXPERIMENTAL
Intervention: Pazopanib
Number of subjects: 246
Study: 29089356

Group type: EXPERIMENTAL
Intervention: Spironolactone (40 mg orally, twice daily) for 2 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 30
Study: 26699125

Group type: EXPERIMENTAL
Intervention: ASSIST nomination process
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention schools
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three simple questions for identification
Number of subjects: 0
Study: 25040433

Group type: EXPERIMENTAL
Intervention: Tablet-based interactive distraction (TBID)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Midazolam (0.5 mg·kg(‐1); 20 mg max)
Number of subjects: 108
Study: 21678167

Group type: EXPERIMENTAL
Intervention: Expressive Writing (EW) about body concerns
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control writing condition
Number of subjects: 111
Study: 20737167

Group type: EXPERIMENTAL
Intervention: Men (intervention group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Neutral and supinated positions (intervention group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Prone position (intervention group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All forearm positions (intervention group)
Number of subjects: 16
Study: 19219086

Group type: EXPERIMENTAL
Intervention: Enrolled in the program
Number of subjects: 11610

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11610
Study: 15982127

Group type: EXPERIMENTAL
Intervention: Global optic flow rate manipulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Edge rate manipulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Global optic flow rate
Number of subjects: 0
Study: 12605342

Group type: EXPERIMENTAL
Intervention: Leptin treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal-weight persons
Number of subjects: 0
Study: 11136260

Group type: EXPERIMENTAL
Intervention: Inhaled triamcinolone acetonide 600 microg twice daily
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1116
Study: 8817984

Group type: EXPERIMENTAL
Intervention: Nikkiso centrifugal pump during CPB
Number of subjects: 23
Study: 1449922

Group type: EXPERIMENTAL
Intervention: +/- Candoxatrilat
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 6208231

Group type: EXPERIMENTAL
Intervention: Tyrosine-adsorbed Dpt extract
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 18
Study: 31386180

Group type: EXPERIMENTAL
Intervention: Intravenous iron
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral iron
Number of subjects: 0
Study: 29735484

Group type: EXPERIMENTAL
Intervention: Inclisiran 200 mg single dose
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Inclisiran 300 mg 2-dose regimen (100 mg on day 1 and 300 mg on day 90)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Inclisiran 300 mg 2-dose regimen
Number of subjects: 501
Study: 26932420

Group type: EXPERIMENTAL
Intervention: High temporal structure attorney questioning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct examination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low temporal structure attorney questioning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cross-examination
Number of subjects: 0
Study: 24591266

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Melatonin
Number of subjects: 26
Study: 23044303

Group type: EXPERIMENTAL
Intervention: Metformin (n = 41)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Pioglitazone (n = 40)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Antioxidant treatment using lipoic acid
Number of subjects: 81

Group type: COMPARATOR
Intervention: Normal Control Group (NC group, n = 79)
Number of subjects: 81
Study: 20492627

Group type: EXPERIMENTAL
Intervention: Shampoo treatment with ultrapure soft water (UPSW)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Shampoo treatment with tap water
Number of subjects: 11
Study: 18579755

Group type: EXPERIMENTAL
Intervention: Progressive Addition Lenses (PALs) with near addition of +1.50 D for 18 months
Number of subjects: 92

Group type: COMPARATOR
Intervention: Single-Vision Lenses (SVLs) for 18 months
Number of subjects: 92
Study: 16075658

Group type: EXPERIMENTAL
Intervention: Escitalopram (10-20 mg/day)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Paroxetine (20-50 mg/day)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 121

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 121
Study: 11921320

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus hormonal therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard radiotherapy
Number of subjects: 0
Study: 9696733

Group type: EXPERIMENTAL
Intervention: Primaquine, 30 mg/d for 15 weeks
Number of subjects: 176
Study: 9156956

Group type: EXPERIMENTAL
Intervention: Amlodipine (5-10 mg once daily)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo (during the 4-week withdrawal phase)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 226
Study: 2649379

Group type: EXPERIMENTAL
Intervention: Identification of non-Hodgkin's lymphomas (NHL) among patients originally diagnosed as HD.
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Diagnosis of Hodgkin's disease (HD)
Number of subjects: 312
Study: 1115011

Group type: EXPERIMENTAL
Intervention: 0.8 mg of pyridoxine hydrochloride
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2.0 mg of pyridoxine hydrochloride
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 20.0 mg of pyridoxine hydrochloride
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diet deficient in vitamin B6
Number of subjects: 24
Study: 31805778

Group type: EXPERIMENTAL
Intervention: EMDR
Number of subjects: 37

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 37
Study: 29535340

Group type: EXPERIMENTAL
Intervention: Anodal HD-tDCS
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cathodal HD-tDCS
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham (control)
Number of subjects: 45
Study: 26847922

Group type: EXPERIMENTAL
Intervention: Low unsaturated long-chain phosphatidylcholines and lysophosphatidylcholines species
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Circulating kynurenine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Decrease of glycerophospholipids
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cardiovascular SOFA score
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Renal replacement therapy
Number of subjects: 20
Study: 24971340

Group type: EXPERIMENTAL
Intervention: Lokomat
Number of subjects: 7

Group type: COMPARATOR
Intervention: Manual Treadmill
Number of subjects: 7

Group type: COMPARATOR
Intervention: ZeroG
Number of subjects: 7

Group type: COMPARATOR
Intervention: Manual Treadmill and ZeroG
Number of subjects: 7
Study: 22404731

Group type: EXPERIMENTAL
Intervention: Risperidone plus divalproate
Number of subjects: 41

Group type: COMPARATOR
Intervention: Haloperidol plus divalproate
Number of subjects: 41
Study: 20176498

Group type: EXPERIMENTAL
Intervention: High-dose GH group (0.012 mg/kg/day)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Low-dose GH group (0.006 mg/kg/day)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 96
Study: 18803944

Group type: EXPERIMENTAL
Intervention: Oral D-chiro-inositol (DCI) supplementation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11